| 000 | 01579 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513132615.0 | ||
| 264 | 0 | _c19980218 | |
| 008 | 199802s 0 0 eng d | ||
| 022 | _a0340-6245 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorishima, Y | |
| 245 | 0 | 0 |
_aAntithrombotic and hemorrhagic effects of DX-9065a, a direct and selective factor Xa inhibitor: comparison with a direct thrombin inhibitor and antithrombin III-dependent anticoagulants. _h[electronic resource] |
| 260 |
_bThrombosis and haemostasis _cNov 1997 |
||
| 300 |
_a1366-71 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticoagulants _xpharmacology |
| 650 | 0 | 4 |
_aAntithrombin III _xanalysis |
| 650 | 0 | 4 |
_aArginine _xanalogs & derivatives |
| 650 | 0 | 4 | _aBleeding Time |
| 650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFactor Xa Inhibitors |
| 650 | 0 | 4 |
_aHemorrhage _xblood |
| 650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNaphthalenes _xpharmacology |
| 650 | 0 | 4 |
_aPeptide Hydrolases _xanalysis |
| 650 | 0 | 4 |
_aPipecolic Acids _xpharmacology |
| 650 | 0 | 4 |
_aPropionates _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aSulfonamides |
| 650 | 0 | 4 |
_aThrombin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aThrombosis _xblood |
| 700 | 1 | _aTanabe, K | |
| 700 | 1 | _aTerada, Y | |
| 700 | 1 | _aHara, T | |
| 700 | 1 | _aKunitada, S | |
| 773 | 0 |
_tThrombosis and haemostasis _gvol. 78 _gno. 5 _gp. 1366-71 |
|
| 999 |
_c9377610 _d9377610 |
||